Chronic Obstructive Pulmonary Diseases-Journal of the COPD Foundation
Scope & Guideline
Exploring innovative solutions for pulmonary challenges.
Introduction
Aims and Scopes
- Clinical Management of COPD:
The journal emphasizes research on clinical practices related to the diagnosis, treatment, and management of COPD, including pharmacological interventions, rehabilitation strategies, and the impact of comorbidities. - Epidemiological Studies:
There is a strong focus on understanding the prevalence, risk factors, and health outcomes associated with COPD, often through large-scale population studies and registries. - Patient-Centered Research:
Research that highlights patient experiences, quality of life, and self-management strategies for COPD patients is a core area. This includes qualitative studies that explore the psychosocial aspects of living with the disease. - Innovative Therapeutics and Interventions:
The journal publishes studies on novel treatments and interventions, such as biologics, telemedicine, and dietary impacts, aimed at improving COPD management and patient outcomes. - Health Disparities and Access to Care:
Research addressing disparities in COPD care among different populations, including socioeconomic and racial/ethnic inequalities, is a significant focus area. - Pathophysiology and Biomarkers:
Investigations into the underlying mechanisms of COPD, including genetic factors, inflammation, and the role of biomarkers in disease progression, are regularly featured.
Trending and Emerging
- Impact of Lifestyle Factors:
Recent publications increasingly explore the effects of lifestyle factors, including diet, physical activity, and smoking cessation, on COPD outcomes, highlighting the importance of holistic management. - Quality of Life and Patient Experience:
There is a notable trend towards emphasizing the quality of life and patient experiences in COPD management, with studies focusing on psychosocial aspects, self-management, and patient-reported outcomes. - Telemedicine and Remote Monitoring:
The integration of telemedicine and remote monitoring tools for COPD management has gained significant attention, particularly in the context of the COVID-19 pandemic, reflecting a shift towards innovative care delivery models. - Health Disparities Research:
The journal has seen a rise in studies addressing health disparities in COPD, focusing on the experiences of underrepresented populations and the impact of sociodemographic factors on care outcomes. - Microbiome and Gut-Lung Interactions:
Emerging research on the role of the microbiome and gut-lung interactions in COPD pathogenesis has gained traction, indicating a growing interest in understanding the disease through a broader biological lens.
Declining or Waning
- Traditional Pharmacological Approaches:
There appears to be a waning focus on traditional pharmacological treatments for COPD, such as long-acting bronchodilators and inhaled corticosteroids, as newer therapeutic modalities and personalized medicine approaches gain traction. - Basic Science Research:
The journal has seen a reduction in the publication of basic science studies that do not directly translate to clinical applications, as there is a stronger emphasis on translational research and patient-centered studies. - Longitudinal Cohort Studies:
While still relevant, the frequency of longitudinal cohort studies focusing solely on COPD progression without integrating patient-reported outcomes or quality of life metrics seems to be decreasing. - General COPD Awareness Campaigns:
Research focused on general awareness and educational campaigns regarding COPD has diminished, possibly due to a shift towards more targeted interventions and specific patient populations.
Similar Journals
RESPIRATORY MEDICINE
Advancing the Frontiers of Pulmonary HealthRespiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.
COPD-Journal of Chronic Obstructive Pulmonary Disease
Advancing knowledge in respiratory health.COPD - Journal of Chronic Obstructive Pulmonary Disease is a premier peer-reviewed journal published by Taylor & Francis Inc. that focuses on the latest advancements in the understanding, diagnosis, and treatment of chronic obstructive pulmonary disease (COPD). As an Open Access journal since 2022, it enhances availability and dissemination of groundbreaking research, allowing researchers, healthcare professionals, and students to access vital information without barriers. The journal has established itself as a significant resource in pulmonary and respiratory medicine, boasting a commendable Q2 ranking in both medicine and specialty areas as of 2023, with an impressive Scopus rank of 66 out of 155. By bridging the gap between scientific exploration and clinical application, COPD aims to foster innovative approaches to managing this prevalent condition, making it an essential publication for those dedicated to improving patient care and advancing respiratory health.
BMJ Open Respiratory Research
Driving breakthroughs in respiratory health for a healthier tomorrow.BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.
BMC Pulmonary Medicine
Connecting researchers and practitioners for impactful insights.BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.
Pulmonary Circulation
Exploring breakthroughs in respiratory medicine.Pulmonary Circulation is a leading open-access journal published by Wiley, focused on advancing the field of pulmonary and respiratory medicine. Established in 2011, the journal has garnered a prestigious reputation, achieving a Q2 ranking in 2023 among its category and ranking #70 out of 155 in Scopus within the specialty of Medicine – Pulmonary and Respiratory Medicine, reflecting its growing influence and relevance in the scientific community. With its commitment to delivering high-quality, peer-reviewed research, Pulmonary Circulation serves as a vital resource for researchers, clinicians, and students seeking to explore innovative ideas and findings in lung health, pulmonary vascular diseases, and therapeutic approaches. The journal has been open access since 2017, ensuring that groundbreaking research is accessible to a wider audience, thus promoting collaboration and knowledge exchange in this dynamic field. Located in the heart of the United States at 111 River St, Hoboken, NJ 07030-5774, the journal is dedicated to fostering advancements in pulmonary health and addressing real-world challenges facing patients globally.
International Journal of Chronic Obstructive Pulmonary Disease
Empowering Research for Better Lung HealthThe International Journal of Chronic Obstructive Pulmonary Disease, published by DOVE MEDICAL PRESS LTD, serves as a premier platform for researchers and professionals involved in the study and management of COPD. Established in 2006 and transitioning to an Open Access model in 2009, this journal has quickly gained a reputable standing in various impactful categories, achieving Q1 rankings in Health Policy, Medicine (Miscellaneous), and Public Health, among others. With a focus on disseminating high-quality research, the journal is pivotal for addressing global public health challenges associated with chronic obstructive pulmonary disease. The journal's dedication to open access ensures that vital information reaches a broader audience, fostering advancements in research and clinical practice. By maintaining rigorous peer-review standards and a commitment to the advancement of understanding in COPD, the journal attracts significant contributions from scientists and practitioners worldwide, making it an invaluable resource for ongoing education and research development in this critical area.
RESPIROLOGY
Championing Collaborative Research in RespirologyRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
Pulmonary Medicine
Navigating the Landscape of Pulmonary MedicinePulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.
RESPIRATORY RESEARCH
Shaping the Future of Pulmonary Medicine TogetherRESPIRATORY RESEARCH is a leading open-access journal published by BMC, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2000, this journal has provided a vital platform for disseminating high-quality research, covering a broad spectrum of topics from basic science to innovative clinical practices in respiratory health. With an impressive impact factor and a Q1 ranking in the Pulmonary and Respiratory Medicine category, RESPIRATORY RESEARCH is recognized for its significant contribution to the literature, currently positioned at rank #19 out of 155 in the Scopus database, highlighting its relevance and influence within the medical community. The journal’s commitment to open access ensures that all articles are freely available to researchers, professionals, and students, fostering collaboration and knowledge sharing in the field. With its convergence years spanning from 2000 to 2024, RESPIRATORY RESEARCH remains at the forefront of respiratory medicine research, making it an essential resource for all stakeholders in this vital medical domain.
Pulmonology
Elevating knowledge and practice in pulmonary medicine.Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.